Outcomes of Bone Metastases treated with Radiotherapy in Lung Cancer

Recruiting

• Conditions: Malignant neoplasm of overlappingsites of bronchus and lung,

• Registration Number: CTRI/2020/04/024780
• Lead Sponsor: Dr Anil Tibdewal

Brief Summary

Consecutive patients eligible for study will be recruited and will be treated with radiotherapy using institutional dose fractionation. Pain response will be assessed at 2 and 4 weeks using Visual Analogue Pain Scale.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2020-03-09
• Study Start: 2020-04-27

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

• 1.All consecutive patients with histologically proven lung cancer with radiologically confirmed bone metastases and planned for radiotherapy at TMH.
• 2.All patients planned for radiotherapy at Tata Memorial Hospital.

Exclusion Criteria

• 1.Age <18 years 2.Patients who are not willing to come for follow up after EBRT completion.
• 3.Patients with spinal cord compression at presentation.
• 4.Patients requiring reirradiation at the previously treated site.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate objective pain response at 2 and 4 weeks (+/-3 days) in lung cancer patients treated with radiotherapy for bone metastases	2 and 4 weeks

Secondary Outcome Measures

Name	Time	Method
To evaluate objective pain response of assessable patients at 3 and 6 months	Time to reirradiation for the same site

Trial Locations

Locations (1)

Tata Memorial Hospital; 🇮🇳 Mumbai, MAHARASHTRA, India

Tata Memorial Hospital

🇮🇳Mumbai, MAHARASHTRA, India

Dr Anil Tibdewal

Principal investigator

022-24177000

aniltibdewal@gmail.com